
Dhampur Bio Q2 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 4
Margin
Category 4
Fundraise
No
Order
N/A
Capex
No
0 of 4 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 4- Sugar sales volumes increased by 5% YoY in Q2 FY25; focus on institutional sales is driving better pricing and volumes.
- Efforts underway to increase sugar sales in non-traditional, non-Asian segments from 25% currently to 60-70% over the next 2 years.
- Ethanol supply for the current season is expected at around 6.5 kilo liters versus about 3-4.5 kilo liters last season, indicating growth in ethanol volumes.
- Grain ethanol capacity utilization expected to improve as remaining plants commence production, with flexibility to participate in future ethanol tenders.
- Country liquor segment shows steady volume growth, necessitating marginal capex to increase bottling capacity.
- Management expects no major capex in sugar capacity but will focus on value addition initiatives to boost realization.
- Overall, company aims for volume growth across sugar, ethanol, and liquor segments while enhancing realization via premiumization and efficiency improvements.
See what Dhampur Bio management said on margin guidance — free account, 30 seconds.
Fundraise plans
No- No explicit mention of new fundraising through debt or equity in the call transcript.
- Current long-term loan stands at INR239 crores as of 30th September 2024, with a comfortable debt equity ratio of 0.24.
- The company has been repaying long-term loans (around INR34 crores repaid during first half).
- Interest cost has increased due to higher inventory and deployment of internal accruals towards capex.
- Management emphasizes maintaining a strong and healthy balance sheet.
- No indication of plans for fresh debt or equity issue; focus is on utilizing internal accruals and managing existing loans.
- Future initiatives and capex are planned within existing financial structures; any major capex decisions deferred based on market conditions.
See what Dhampur Bio management said on order book — free account, 30 seconds.
Capex plans
No- No major capex or capacity enhancement plans for sugar segment in the foreseeable future; focus remains on value addition and efficiency improvements.
- Marginal capex planned for increasing bottling capacity in country liquor segment due to steady volume growth; these are nominal and not substantial.
- Grain-based ethanol facility capex of around INR 94 crores (INR 48 crores grain-based, rest normal) is ongoing with capitalization expected soon.
- Interest subvention available on grain-based ethanol capex with approximately INR 40 crores loans qualifying for 50% interest support.
- Plant commissioning for grain-based ethanol expected before end of year; tender-related bidding may happen once operational.
- Management and board continuously review options including buyback/dividend if surplus cash and no material reinvestment needs arise.
- No immediate plans for further large-scale capital investments; focus on maintaining healthy balance sheet and sustainable growth.
Track Dhampur Bio — get its next earnings analysis in your feed
How does Dhampur Bio rank vs peers in Agricultural Food & other Products?
Pro featureHow does Dhampur Bio rank in Agricultural Food & other Products?
Compare Dhampur Bio against every Agricultural Food & other Products company (Q2 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Dhampur Bio's management said in earlier quarters
Others in Agricultural Food & other Products this season
- M.V.K. Agro (Q2 FY27)
For the quarter ended September 30, 2026, MVK Agro Food Product Ltd reported revenue from operations of ₹6,145.91 lakhs, up from ₹4,215.70 lakhs in the same…
- Gokul Refoils (Q2 FY27)
17,449.65 lakhs (approximately 16.4% growth) . Key results statement takeaways from Gokul Refoils and Solvent Ltd's Q2 FY27 results statement — and how it ranks
- Patanjali Foods (Q2 FY27)
11,322.58 crores, up 15.55% YoY. Key results statement takeaways from Patanjali Foods Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- GRM Overseas (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹452.6 Cr, up 22% YoY from ₹372.4 Cr in Q2 FY26 (Page 8) . Key investor presentation takeaways from GRM Overseas Ltd's Q2 FY27